Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Abbott co-promotes BI's Mobic, Micardis; ends deal early

Executive Summary

Abbott Laboratories has licensed eight-year US co-promotion rights to Boehringer Ingelheim's antihypertensive Micardis (telmisartan), in addition to its osteoarthritis drug Mobic (meloxicam).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Co-Promotion
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register